Oxford BioDynamics (LON:OBD) Hits New 12-Month Low – Here’s Why
by Doug Wharley · The Cerbat GemShares of Oxford BioDynamics Plc (LON:OBD – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 0.15 and last traded at GBX 0.16, with a volume of 16345429 shares trading hands. The stock had previously closed at GBX 0.17.
Oxford BioDynamics Stock Down 2.4%
The firm has a market cap of £6.91 million, a P/E ratio of -0.20 and a beta of 0.42. The company’s 50 day simple moving average is GBX 0.19 and its 200-day simple moving average is GBX 0.23. The company has a current ratio of 0.88, a quick ratio of 2.80 and a debt-to-equity ratio of 457.97.
About Oxford BioDynamics
Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.